|
SLC29A1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.274400E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.50640000000336E-05 |
| Normal-vs-Stage2 |
8.555400E-01 |
| Normal-vs-Stage3 |
5.444600E-01 |
| Normal-vs-Stage4 |
8.445200E-01 |
| Stage1-vs-Stage2 |
1.056030E-01 |
| Stage1-vs-Stage3 |
3.118300E-02 |
| Stage1-vs-Stage4 |
1.092240E-01 |
| Stage2-vs-Stage3 |
8.080200E-01 |
| Stage2-vs-Stage4 |
9.597800E-01 |
| Stage3-vs-Stage4 |
8.862200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.956910E-03 |
| Normal-vs-AfricanAmerican |
8.123200E-01 |
| Normal-vs-Asian |
6.466600E-01 |
| Caucasian-vs-AfricanAmerican |
1.942420E-01 |
| Caucasian-vs-Asian |
6.598000E-01 |
| AfricanAmerican-vs-Asian |
5.969800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.178200E-02 |
| Normal-vs-Female |
4.353800E-01 |
| Male-vs-Female |
2.146400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.726000E-02 |
| Normal-vs-Extreme_Weight |
4.25130000003549E-06 |
| Normal-vs-Obese |
6.066000E-01 |
| Normal-vs-Extreme_Obese |
3.619900E-03 |
| Normal_Weight-vs-Extreme_Weight |
7.932200E-02 |
| Normal_Weight-vs-Obese |
2.822000E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.191200E-01 |
| Extreme_Weight-vs-Obese |
8.100000E-03 |
| Extreme_Weight-vs-Extreme_Obese |
6.144000E-01 |
| Obese-vs-Extreme_Obese |
1.631200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.924000E-01 |
| Normal-vs-Age(41-60Yrs) |
2.131600E-01 |
| Normal-vs-Age(61-80Yrs) |
5.058800E-03 |
| Normal-vs-Age(81-100Yrs) |
1.639920E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.220750E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.552500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.030000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.212200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.988000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.172000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.245900E-02 |
| Normal-VS-Type2 PRCC |
4.793700E-02 |
| Normal-VS-KIRP CIMP |
5.594000E-02 |
| Normal-VS-Unclassified PRCC |
9.050600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.570000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.657000E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
2.125400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.431800E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.344200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.520000E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.112000E-02 |
| Normal-vs-N1 |
2.234000E-01 |
| Normal-vs-N2 |
2.531000E-01 |
| N0-vs-N1 |
1.017620E-01 |
| N0-vs-N2 |
1.450350E-01 |
| N1-vs-N2 |
4.455600E-01 |
|
|
